
FDA Watch: BD Receives FDA Approval for Veritor, a Pandemic Staple
The assay was widely used during the early months of COVID-19 and was a significant source of revenue growth for a time

The assay was widely used during the early months of COVID-19 and was a significant source of revenue growth for a time

The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2

The pandemic may have set the stage for a jump in infections from these four nemeses

Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?

The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options